Clay Rowland
Investment Associate at Mission Biocapital
About
An investment associate in San Francisco supporting new therapeutics investments. He joined the firm in 2025 and previously worked as an associate at the T1D Fund focused on biotech investments and served in corporate development at Syros Pharmaceuticals.
Colleagues at Mission Biocapital
Cassidy Blundell
Partner at Mission Biocapital
Chaya Patel
Principal at Mission Biocapital
Chris Carlin
Chief Operations Officer and Chief Compliance Officer at Mission Biocapital
Douglas Crawford
Managing General Partner at Mission Biocapital
Jennifer Griffin
Partner at Mission Biocapital
Johannes Fruehauf
General Partner at Mission Biocapital
Josephine Brysting
Investment Analyst at Mission Biocapital
Linda Eng
Director of Operations, Bay Area at Mission Biocapital